Greenfield Savings Bank increased its stake in shares of Colgate-Palmolive Company (NYSE:CL – Free Report) by 403.8% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,055 shares of the company’s stock after acquiring an additional 9,662 shares during the quarter. Greenfield Savings Bank’s holdings in Colgate-Palmolive were worth $1,029,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also recently bought and sold shares of CL. Cooper Financial Group grew its holdings in shares of Colgate-Palmolive by 4.0% during the second quarter. Cooper Financial Group now owns 2,947 shares of the company’s stock worth $270,000 after purchasing an additional 114 shares during the last quarter. Gould Capital LLC lifted its holdings in shares of Colgate-Palmolive by 38.7% in the 1st quarter. Gould Capital LLC now owns 412 shares of the company’s stock valued at $35,000 after purchasing an additional 115 shares during the last quarter. Redhawk Wealth Advisors Inc. boosted its position in shares of Colgate-Palmolive by 2.8% in the 2nd quarter. Redhawk Wealth Advisors Inc. now owns 4,326 shares of the company’s stock valued at $397,000 after purchasing an additional 118 shares during the period. SVB Wealth LLC grew its stake in Colgate-Palmolive by 1.4% during the 2nd quarter. SVB Wealth LLC now owns 8,767 shares of the company’s stock worth $804,000 after buying an additional 119 shares during the last quarter. Finally, ANB Bank grew its stake in Colgate-Palmolive by 1.7% during the 1st quarter. ANB Bank now owns 7,200 shares of the company’s stock worth $614,000 after buying an additional 120 shares during the last quarter. 80.41% of the stock is owned by hedge funds and other institutional investors.
Colgate-Palmolive Stock Performance
Colgate-Palmolive stock traded up $0.01 during trading hours on Wednesday, reaching $87.26. 3,773,453 shares of the stock were exchanged, compared to its average volume of 5,712,208. Colgate-Palmolive Company has a 52-week low of $74.54 and a 52-week high of $99.33. The stock has a market cap of $69.56 billion, a P/E ratio of 34.63, a P/E/G ratio of 4.02 and a beta of 0.33. The company has a debt-to-equity ratio of 13.82, a quick ratio of 0.67 and a current ratio of 1.03. The firm’s 50 day moving average is $89.23 and its 200 day moving average is $88.75.
Colgate-Palmolive Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Tuesday, October 20th will be given a dividend of $0.53 per share. The ex-dividend date is Tuesday, October 20th. This represents a $2.12 annualized dividend and a yield of 2.4%. Colgate-Palmolive’s payout ratio is presently 84.13%.
Insiders Place Their Bets
In related news, Director John T. Cahill sold 4,170 shares of Colgate-Palmolive stock in a transaction that occurred on Thursday, August 6th. The stock was sold at an average price of $93.37, for a total value of $389,352.90. Following the sale, the director directly owned 28,373 shares in the company, valued at $2,649,187.01. The trade was a 12.81% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, COO Panagiotis Tsourapas sold 10,000 shares of the company’s stock in a transaction on Monday, August 24th. The stock was sold at an average price of $92.05, for a total value of $920,500.00. Following the transaction, the chief operating officer directly owned 64,901 shares in the company, valued at $5,974,137.05. This represents a 13.35% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders have sold 175,191 shares of company stock worth $16,110,903. Company insiders own 0.43% of the company’s stock.
Analysts Set New Price Targets
A number of equities research analysts have weighed in on the company. Sanford C. Bernstein reiterated a “market perform” rating on shares of Colgate-Palmolive in a research note on Thursday, August 13th. Piper Sandler cut their target price on shares of Colgate-Palmolive from $98.00 to $95.00 and set an “overweight” rating on the stock in a report on Monday, September 21st. UBS Group upped their price target on shares of Colgate-Palmolive from $106.00 to $109.00 and gave the company a “buy” rating in a research report on Monday, August 3rd. Royal Bank Of Canada reissued an “outperform” rating and set a $104.00 price objective on shares of Colgate-Palmolive in a research report on Tuesday, September 8th. Finally, Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a $101.00 price objective on shares of Colgate-Palmolive in a research note on Monday, August 3rd. Twelve equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $98.65.
Check Out Our Latest Analysis on Colgate-Palmolive
Colgate-Palmolive Profile
Colgate-Palmolive Company (NYSE: CL) is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its portfolio includes toothpaste, toothbrushes, mouthwashes, body washes, deodorants, soaps, household cleaning products and pet food and treats.
The company markets many of its products under well-known brands, including Colgate, Palmolive, elmex, meridol, Protex, Softsoap, Ajax, Irish Spring, Speed Stick, Tom’s of Maine and Hill’s Science Diet.
See Also
- Five stocks we like better than Colgate-Palmolive
- Skydance Just Became a Media Giant—With an $80 Billion Debt Load
- Could Velo3D Be the Next Defense Buyout Target?
- Penguin Solutions Is Soaring as AI Memory Demand Explodes
- Alphabet’s Chart Is Coiling—and the Fundamentals May Be Ready to Back It Up
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.
